Marcos Garcia-Lacarte

I work at the intersection of immunology, genomics, and data science, with a special focus on cancer research. I have a strong background in T cell profiling and a multidisciplinary skill set that combines wet-lab experimentation with advanced computational analysis, particularly in studying immune–tumor interactions.

Currently, I’m a bioinformatician in the Church group at the Centre for Human Genetics, University of Oxford, where I lead data analysis for the LynchVax project—an initiative aimed at developing a preventive cancer vaccine for individuals with Lynch Syndrome. I integrate multi-omics data (WGS, WES, RNA-seq, spatial transcriptomics, proteomics) to analyze T cell function and identify tumor-derived neoepitopes as potential vaccine candidates. Additionally, I also develop analytical tools and pipelines, contribute to scientific publications, and support data infrastructure across the project.

I am a multidisciplinary researcher with extensive experience in immunology, genomics, and data science. Trained as a biotechnologist, I later specialized in transcriptomic biomarkers and cancer immunology at the University of Navarra. My work integrates experimental and computational approaches, with strong practical expertise in molecular biology, next-generation sequencing, and preclinical cancer models.

Throughout my trajectory, I have led and contributed to research projects investigating immune evasion in cancer, particularly in lymphomas. By integrating transcriptomic and immunological profiling techniques, my work has aimed to elucidate tumor–immune interactions and support the development of novel therapeutic strategies.